AGER and cancer: ,8,9,10,11,12,13 Among several receptors that convey HMGB1-induced signaling, the receptor for advanced glycation end products (RAGE) is increased in many cancers, including those derived from the breast, colon, pancreas, and brain, and has been associated with autophagy, proliferation, angiogenesis, and resistance to chemotherapy.14